Corbus Pharmaceuticals (CRBP) Earnings (2013 - 2026)
Corbus Pharmaceuticals (CRBP) earnings from Sep 30, 2013 to Mar 31, 2026. The TTM Corbus Pharmaceuticals (CRBP) earnings is -$85M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Corbus Pharmaceuticals (CRBP) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +68.07% |
| 3 Years TTM | +18.61% |
| 5 Years TTM | -1.05% |
| 10 Years TTM | +23.55% |
| All Time TTM | +43.96% |
Annual Earnings change of Corbus Pharmaceuticals (CRBP)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$23M | -70.75% |
| 2025 | -$79M | +95.32% |
| 2024 | -$40M | -9.84% |
| 2023 | -$45M | +5.31% |
| 2022 | -$42M | -7.21% |
| 2021 | -$46M | -58.98% |
| 2020 | -$111M | +55.73% |
| 2019 | -$71M | +28.35% |
| 2018 | -$56M | +71.71% |
| 2017 | -$32M | +62.10% |
| 2016 | -$20M | +125.99% |
| 2015 | -$8.85M | +248.43% |
| 2014 | -$2.54M | +323.33% |
| 2013 | -$600K | N/A |
Comparison Corbus Pharmaceuticals (CRBP) five years earnings CAGR with competitors
Corbus Pharmaceuticals (CRBP) five years earnings CAGR is -6.57%.